Navigation Links
ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS
Date:2/3/2009

IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it is prepared to respond aggressively to the patent lawsuit brought against it by ZOLL Circulation, Inc., a subsidiary of ZOLL Medical Corporation (Nasdaq: ZOLL). Alsius was sued by ZOLL based on two temperature management patents ZOLL purchased from a defunct competitor of Alsius'. Alsius believes that its patents do not infringe on the ZOLL patents, and that ZOLL's core temperature management patents are invalid. Alsius believes that it retains a dominant patent position in intravascular cooling that, among other things, precludes any competitor from marketing an intravascular cooling catheter for therapeutic hypothermia in patients who have had cardiac arrest or heart attack. ZOLL has not yet sold temperature management products based on ZOLL's patents.

About Alsius Corporation

Alsius, the worldwide leader in intravascular temperature management, develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the largely unmet clinical need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients. For more information, visit www.alsius.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Alsius' future financial or business performance. These statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including the risks described from time to time in Alsius' filings with the Securities and Exchange Commission. These risks include, but are not limited to, the fact that Alsius must raise additional funds before the end of the second quarter of 2009 to continue its operations and finance the litigation described herein, uncertainty in the market for sales of medical equipment, and uncertainty in any complex litigation such as the litigation between Alsius and ZOLL described herein. Alsius undertakes no duty to update any forward-looking statements made herein, except as required by law.


'/>"/>
SOURCE Alsius Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
2. Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress
3. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
4. Alsius Corporation Awarded Three-Year Agreement With Premier, Inc.
5. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
6. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
7. Alsius Corporation Receives Regulatory Approval in China and Mexico
8. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
9. Alsius Corporation Announces Program for Early Exercise of Warrants
10. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
11. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , ... April 28, 2016 , ... Head Over Heels ... 9 Western Championships. The competition will be held at the University of Montana on ... gymnasts west of the Mississippi River. , In order to qualify, Varize needed to ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... open availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. ... This innovative standard will make it possible to build applications that generate ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online ... cosmetictown.com . The forum section was recently revamped and upgraded to allow even more ... in use across the country. , According to the senior editor of Cosmetic Town, ...
(Date:4/28/2016)... ... 2016 , ... Greener Hydroponics is now offering a large selection of Smart ... organic farmers and nurseries according to Sales Manager Joe Steele who says, “Now is ... is to offer wholesale level pricing and ultra-fast shipping for growers of any size.” ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
(Date:4/27/2016)... 2016 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends, and ... global skincare devices market was valued at US$ 7,255.8 ... a CAGR of 10.1% from 2015 to 2023 to ... the full Skincare Devices Market (Treatment Device - LED Therapy ...
Breaking Medicine Technology: